BioTech | 31 May 2023 | Opinion
“We'll focus on genomic medicine and growing our business in China”
What is the strategic rationale for the merger, and how does it fit into the long-term growth plans of both co...Read more
Pharma | 31 May 2023 | Opinion
What are some of your key areas of focus in R&D and what’s your approach toward pharma innovation?&n...Read more
World | 02 May 2023 | Opinion
Importance of HPV Testing and Genotyping in Cervical Cancer Prevention
Dr. Mohd Azizuddin bin Mohd Yussof, CT (IAC), Bsc. (Biomedical), MHealthSc. (Biomedical), PhD (Pathology) is t...Read more
Medical Diagnostic | 31 May 2023 | Opinion
“We plan to manufacture one million tests of VANSCAN Typhoid RT PCR test in our first year in India”
Please share some details about the global Typhoid Diagnostics market. Where does India stand in terms of dise...Read more
Japan | 17 May 2023 | News
Japan's Astellas Pharma enters into cancer research collaboration with Sony Corporation
Japan headquartered Sony Corporation and Astellas Pharma Inc. have entered into a collaborative rese...Read more
Japan | 12 May 2023 | News
Japan's Otsuka Pharma gets US FDA nod for drug to treat agitation during Alzheimer's
The US Food and Drug Administration (FDA) has announced the supplemental approval of Rexulti (brexpiprazo...Read more
World | 08 May 2023 | News
Junshi Biosciences, Dr. Reddy’s to develop and commercialise oncology drug in 21 countries
Shanghai Junshi Biosciences Co. has collaborated with Indian pharmaceutical firm Dr. Reddy’s Laboratorie...Read more
Japan | 29 May 2023 | News
Japan's Shimadzu signs comprehensive collaboration agreement with Osaka University
Japan-headquartered Shimadzu Corporation as signed an agreement with Osaka University (OU) with the aim of imp...Read more
Thailand | 24 May 2023 | News
Thailand develops nasal spray with highly effective antibodies against COVID-19
A research team at the Centre of Excellence in Systems Biology, Faculty of Medicine, Chulalongkorn Univer...Read more
Singapore | 17 May 2023 | News
Korean firm Next&Bio to establish subsidiary in Singapore to prepare for global expansion
Next&Bio Inc., a South Korea-based startup that has developed an organoid-based precision medicine dr...Read more
Australia | 12 May 2023 | News
Australia develops AI tool to predict Parkinson's disease onset
Scientists from University of South Wales (UNSW) Sydney, Australia with collaborators at Boston University, US...Read more
Europe | 29 May 2023 | News
Medtronic to acquire wearable insulin patch maker EOFlow in Korea for $738 M
Medtronic plc, Ireland-headquartered healthcare technology firm, has entered into a set of definitive agr...Read more
Thailand | 26 May 2023 | News
China-based Tianlong helps hospitals in Thailand for early detection of hepatitis
Tianlong, an innovative high-tech company specialising in molecular diagnostic products in China, has partnere...Read more
Singapore | 23 May 2023 | News
Singapore offers novel therapy to improve age-related frailty and metabolic disorders
A decline in functional mobility, loss of muscle strength and an increase in body fats are often associated wi...Read more
Singapore | 24 May 2023 | News
West Pharmaceutical Services inaugurates advanced manufacturing facility in Singapore
West Pharmaceutical Services, Inc. (West), a global leader in innovative solutions for injectable drug adminis...Read more
China | 19 May 2023 | News
GenScript expands peptide and oligonucleotide production facility in China
US-based GenScript Biotech Corporation has expanded its primary manufacturing facility for oligonucleotide and...Read more
Korea | 04 May 2023 | News
Merck to open new Asia-Pacific Bioprocessing Centre in South Korea
US-based science and technology company, Merck has signed a non-binding Memorandum of Understanding (MoU) with...Read more
China | 25 April 2023 | News
OBiO Technology opens super factory in China to accelerate cell & gene therapy
OBiO Technology (Shanghai) Corp., a leading gene and cell therapy contract development and manufacturing organ...Read more
TAPPING FULL POTENTIAL OF NANOPARTICLES
Nanoparticles are another powerful tool in the biotech industry’s arsenal for targeted drug delivery. Their extremely small size, measured in nanometres, makes them highly effective carriers for therapeutic agents. These miniature carriers can be customised to encase drugs, benefiting from their biocompatibility, controlled release capabilities, stability, and low toxicity. The precision offered by nanoparticles opens up a world of possibilities for treating various diseases, including infectious diseases, cancer, and neurological disorders. These tiny particles offer tremendous potential for targeted drug delivery, enhanced therapeutic efficacy and precise disease targeting. Moreover, the global market for nanoparticle drug delivery is projected to grow significantly, reaching $123.6 billion by 2025, according to BCC Research. Let’s deep dive into the fascinating field of nanomedicines, advancements and challenges in nanoparticle drug delivery.
For Feedback Email Us: communications@biospectrumasia.com
1 North Bridge Road,
#08-08 High Street Centre,
Singapore 179094
Email : communications@biospectrumasia.com
+65 90150305
